UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Poster #217 EFFICACY AND ACCEPTABILITY OF BENZODIAZEPINE AUGMENTATION OF ANTIPSYCHOTICS IN SCHIZOPHRENIA AND SCHIZOPHRENIA-LIKE PSYCHOSES: A META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS

Schizophrenia research, 2012-04, Vol.136, p.S264-S264

Leucht, Markus Dold, Stefan

2012

Volltextzugriff (PDF)

Diltiazem Reduces Restenosis After Percutaneous Transluminal Coronary Angioplasty

Journal of interventional cardiology, 1996-08, Vol.9 (4), p.287-295

1996

Volltextzugriff (PDF)

Pharmacotherapy of treatment-resistant schizophrenia: a clinical perspective

Evidence-based mental health, 2014-05, Vol.17 (2), p.33-37

2014

Volltextzugriff (PDF)

Efficacy of pharmacotherapy and psychotherapy for adult psychiatric disorders: a systematic overview of meta-analyses

JAMA psychiatry (Chicago, Ill.), 2014-06, Vol.71 (6), p.706

2014

Volltextzugriff (PDF)

Efficacy, Acceptability, and Tolerability of Antipsychotics in Treatment-Resistant Schizophrenia: A Network Meta-analysis

JAMA psychiatry (Chicago, Ill.), 2016-03, Vol.73 (3), p.199

2016

Volltextzugriff (PDF)

Prioritization of Psychopathological Symptoms and Clinical Characterization in Psychiatric Diagnoses: A Narrative Review

JAMA psychiatry (Chicago, Ill.), 2024-09

2024

Volltextzugriff (PDF)

Putting the efficacy of psychiatric and general medicine medication into perspective: review of meta-analyses

British journal of psychiatry, 2012-02, Vol.200 (2), p.97-106

2012

Volltextzugriff (PDF)

Reducing antipsychotic drugs in stable patients with chronic schizophrenia or schizoaffective disorder: a randomized controlled pilot trial

European archives of psychiatry and clinical neuroscience, 2021-03, Vol.271 (2), p.293-302

2021

Volltextzugriff (PDF)

Multifactorial barriers in the implementation of schizophrenia and psychosocial therapies guidelines: A quantitative study across different professions

Schizophrenia research, 2021-02, Vol.228, p.425-434

2021

Volltextzugriff (PDF)

Benzodiazepine augmentation of antipsychotic drugs in schizophrenia: A meta-analysis and cochrane review of randomized controlled trials

European neuropsychopharmacology, 2013-09, Vol.23 (9), p.1023-1033

2013

Volltextzugriff (PDF)

Haloperidol versus first-generation antipsychotics for the treatment of schizophrenia and other psychotic disorders

Cochrane database of systematic reviews, 2015-01, Vol.1 (1), p.CD009831

2015

Volltextzugriff (PDF)

Lithium for schizophrenia

Cochrane database of systematic reviews, 2015-10, Vol.2015 (10), p.CD003834-CD003834

2015

Volltextzugriff (PDF)

Poster #S232 EFFICACY OF SECOND- VERSUS FIRST-GENERATION ANTIPSYCHOTIC DRUGS FOR TREATMENT-RESISTANT SCHIZOPHRENIA: A SYSTEMATIC REVIEW AND META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS

Schizophrenia research, 2014-04, Vol.153, p.S173-S174

2014

Volltextzugriff (PDF)

The optimization of treatment and management of schizophrenia in Europe (OPTiMiSE) trial: rationale for its methodology and a review of the effectiveness of switching antipsychotics

Schizophrenia bulletin, 2015-05, Vol.41 (3), p.549-558

2015

Volltextzugriff (PDF)

Pharmakotherapie der therapieresistenten Schizophrenie

PSYCH up2date, 2014-09, Vol.8 (5), p.281-297

2014

Volltextzugriff (PDF)

Evidence-based Shared-Decision-Making Assistant (SDM-assistant) for choosing antipsychotics: protocol of a cluster-randomized trial in hospitalized patients with schizophrenia

BMC psychiatry, 2022-06, Vol.22 (1), p.406-406, Article 406

2022

Volltextzugriff (PDF)

Benzodiazepines for schizophrenia

Cochrane database of systematic reviews, 2012-11, Vol.11 (11), p.CD006391

2012

Volltextzugriff (PDF)

Trifluoperazine versus low-potency first-generation antipsychotic drugs for schizophrenia

Cochrane database of systematic reviews, 2014-07, Vol.2014 (7), p.CD009396

2014

Volltextzugriff (PDF)

Carbamazepine for schizophrenia

Cochrane database of systematic reviews, 2014-05, Vol.2014 (5), p.CD001258-CD001258

2014

Volltextzugriff (PDF)

Poster #216 IS HALOPERIDOL MORE EFFECTIVE THAN OTHER FIRST-GENERATION ANTIPSYCHOTICS IN SCHIZOPHRENIA? A META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS

Schizophrenia research, 2012-04, Vol.136, p.S263-S264

2012

Volltextzugriff (PDF)

Modeling determinants of medication attitudes and poor adherence in early nonaffective psychosis: implications for intervention

Schizophrenia bulletin, 2015-05, Vol.41 (3), p.584-596

2015

Volltextzugriff (PDF)

Functional Loss of Terminal Complement Complex Protects Rabbits from Injury-Induced Osteoarthritis on Structural and Cellular Level

Biomolecules (Basel, Switzerland), 2023-01, Vol.13 (2), p.216

2023

Volltextzugriff (PDF)

1 – 25 von 39

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(36)
Mit Volltextzugriff
(32)

Publikationsform

Artikel
(37)
Bücher
(1)
Berichte
(1)

Sprache

Englisch
(37)
Deutsch
(1)

Erscheinungsjahr

n.n

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Poster #217 EFFICACY AND ACCEPTABILITY OF BENZODIAZEPINE AUGMENTATION OF ANTIPSYCHOTICS IN SCHIZOPHRENIA AND SCHIZOPHRENIA-LIKE PSYCHOSES: A META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS

Diltiazem Reduces Restenosis After Percutaneous Transluminal Coronary Angioplasty

Pharmacotherapy of treatment-resistant schizophrenia: a clinical perspective

Efficacy of pharmacotherapy and psychotherapy for adult psychiatric disorders: a systematic overview of meta-analyses

Efficacy, Acceptability, and Tolerability of Antipsychotics in Treatment-Resistant Schizophrenia: A Network Meta-analysis

Prioritization of Psychopathological Symptoms and Clinical Characterization in Psychiatric Diagnoses: A Narrative Review

Putting the efficacy of psychiatric and general medicine medication into perspective: review of meta-analyses

Reducing antipsychotic drugs in stable patients with chronic schizophrenia or schizoaffective disorder: a randomized controlled pilot trial

Multifactorial barriers in the implementation of schizophrenia and psychosocial therapies guidelines: A quantitative study across different professions

Benzodiazepine augmentation of antipsychotic drugs in schizophrenia: A meta-analysis and cochrane review of randomized controlled trials

Haloperidol versus first-generation antipsychotics for the treatment of schizophrenia and other psychotic disorders

Lithium for schizophrenia

Poster #S232 EFFICACY OF SECOND- VERSUS FIRST-GENERATION ANTIPSYCHOTIC DRUGS FOR TREATMENT-RESISTANT SCHIZOPHRENIA: A SYSTEMATIC REVIEW AND META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS

The optimization of treatment and management of schizophrenia in Europe (OPTiMiSE) trial: rationale for its methodology and a review of the effectiveness of switching antipsychotics

Pharmakotherapie der therapieresistenten Schizophrenie

Evidence-based Shared-Decision-Making Assistant (SDM-assistant) for choosing antipsychotics: protocol of a cluster-randomized trial in hospitalized patients with schizophrenia

The impact of a digital guideline version on schizophrenia guideline knowledge: results from a multicenter cluster-randomized controlled trial

Benzodiazepines for schizophrenia

Trifluoperazine versus low-potency first-generation antipsychotic drugs for schizophrenia

Identifying differential predictors for treatment response to amisulpride and olanzapine combination treatment versus each monotherapy in acutely ill patients with schizophrenia: Results of the COMBINE-study

Carbamazepine for schizophrenia

Poster #216 IS HALOPERIDOL MORE EFFECTIVE THAN OTHER FIRST-GENERATION ANTIPSYCHOTICS IN SCHIZOPHRENIA? A META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS

Modeling determinants of medication attitudes and poor adherence in early nonaffective psychosis: implications for intervention

Functional Loss of Terminal Complement Complex Protects Rabbits from Injury-Induced Osteoarthritis on Structural and Cellular Level

Changing the Antipsychotic in Early Nonimprovers to Amisulpride or Olanzapine: Randomized, Double-Blind Trial in Patients With Schizophrenia

Suchergebnisse filtern